Loading
Site Map
-
Monoclonal Generation
-
Custom Recombinant Monoclonal Antibody Generation
- HuCAL Technology Explained
-
HuCAL® Antibody Generation Process
- Antigens and antigen expression services
- Guided Selection Strategies
- Affinity maturation
- Selection of antibodies based on binding strength
- Fab antibody formats and epitope tags
- Conversion of Fab to full immunoglobulin format
- Fab Antibody Production
- Screening and Pair Selection using the Bio-Plex® System
- Flow cytometry antibody screening
- Custom Service Packages, Pricing and Ordering
- Application Resources and Technical Support
-
Webinars, Videos and Technical Articles
- Webinar: Improve your antibody drug development assays
- Webinar: Optimize your assays using recombinant antibodies selected for desired affinity
- Webinar: The making of recombinant anti-idiotypic antibodies for high performance in bioanalytical assays
- Webinar: Human recombinant antibodies as positive controls and calibrators
- Webinar: How to overcome assay challenges using custom recombinant antibodies
- Webinar: Generation of high affinity recombinant antibodies for application in immuno-MRM
- Video: Generating anti-idiotypic antibodies for bioanalytical assays
- Video: Best practices for characterization and QC of anti-idiotypic antibodies for bioanalysis
- Video: Generation of drug-target complex specific antibodies
- Article: Monitoring antibody immune responses against biotherapeutic drugs
- Article: Effective tools for drug monitoring assays
- Article: An accelerated approach to sensitive ADA assays
- Article: Isolation of enzyme active site-specific recombinant antibodies by guided selection
- Article: Biomarker Assay Development using Highly Specific Recombinant Antibodies
- Article: Recombinant antibodies as standards for immunodiagnostic assays
- Article: High affinity antibodies for peptide enrichment immuno-MRM
- Article: Generation of antibodies against self-antigens
- Article: Generation and characterization of drug-target complex-specific antibodies
- Poster: Characterization of anti-idiotypic antibodies for high performance in bioanalytical assays
- Poster: Recombinant anti-idiotypic antibodies for antibody drug development
- Poster: Generation of recombinant antibodies for Bio-Plex assays
- Poster: Drug-Target-Complex Specific Antibodies for Pharmacokinetic Analysis of Biotherapeutics
-
Custom Recombinant Monoclonal Antibody Generation
-
Bioanalytical Antibodies
-
Anti-idiotypic Antibodies
- Anti-Adalimumab Antibodies
- Anti-Alemtuzumab Antibodies
- Anti-Bevacizumab Antibodies
- Anti-Cetuximab Antibodies
- Anti-Denosumab Antibodies
- Anti-Eculizumab Antibodies
- Anti-Etanercept Antibodies
- Anti-Golimumab Antibodies
- Anti-Infliximab Antibodies
- Anti-Natalizumab Antibodies
- Anti-Nivolumab Antibodies
- Anti-Omalizumab Antibodies
- Anti-Palivizumab Antibodies
- Anti-Panitumumab Antibodies
- Anti-Pembrolizumab Antibodies
- Anti-Ranibizumab Antibodies
- Anti-Rituximab Antibodies
- Anti-Tocilizumab Antibodies
- Anti-Trastuzumab Antibodies
- Anti-Ustekinumab Antibodies
- Anti-Vedolizumab Antibodies
- Biosimilar Antibodies for Research Use
- Anti-IgG Fc Antibodies
- Recombinant Fully-Human Immunoglobulin Isotype Controls
- Anti-Biotherapeutic Antibody Quality Control and Characterization
- Characterization of critical reagents for ligand binding assays
-
Anti-idiotypic Antibodies
- Custom Services
-
Clinical Diagnostics
- Antibodies and Antigens for Diagnostic Assay Development and Research
- Endocrinology Antibodies
- Infectious Disease Testing
- Cardiovascular Biomarker Antibodies
- HbA1c Antibodies
- Somatostatin Antibodies
- Tumor Markers
- Leukemia Markers
- Neuroscience Biomarkers
- Coagulation & Hematology Antibodies
- Veterinary Diagnostics
- Immunoglobulins
-
Contact and Support
- Contact Your Local Office
- Worldwide Office Locations
-
Technical Support
- Abbreviations for Formats & Applications
- Antibody Binding Affinities
- FAQs
- Material Safety Datasheets
- License Your Antibody
- Our Guarantees to You
-
Antibody Protocols
-
ELISA Protocols
- General ELISA protocols
-
PK Bridging ELISA Measuring Free Drug Protocols
- Anti-adalimumab
- Anti-bevacizumab
- Anti-cetuximab
- Anti-denosumab
- Anti-eculizumab
- Anti-etanercept
- Anti-golimumab
- Anti-infliximab
- Anti-natalizumab
- Anti-nivolumab
- Anti-omalizumab
- Anti-palivizumab
- Anti-panitumumab
- Anti-pembrolizumab
- Anti-rituximab
- Anti-tocilizumab
- Anti-trastuzumab (HCA166, HCA168)
- Anti-trastuzumab (HCA169, HCA176P)
- Anti-trastuzumab (HCA169, HCA177P)
- Anti-trastuzumab (HCA169, HCA270)
- Anti-ustekinumab (HCA208, HCA210)
- Anti-ustekinumab (HCA209, HCA210)
- Anti-vedolizumab
- PK Bridging ELISA Measuring Total Drug Protocols
-
ADA Bridging Protocols
- Anti-adalimumab IgG1
- Anti-adalimumab IgE
- Anti-bevacizumab
- Anti-cetuximab
- Anti-denosumab
- Anti-eculizumab
- Anti-etanercept
- Anti-infliximab
- Anti-natalizumab
- Anti-nivolumab
- Anti-omalizumab
- Anti-palivizumab
- Anti-panitumumab
- Anti-pembrolizumab
- Anti-ranibizumab
- Anti-trastuzumab
- Anti-ustekinumab
- Anti-vedolizumab
- PK ELISA Antigen Capture Protocols
- Flow Cytometry
- Immunofluorescence
-
Immunohistochemistry
- IHC Protocol 1: Indirect Immunostaining of Frozen Tissue Sections
- IHC Protocol 2: Streptavidin-Biotin Immunostaining of Frozen Tissue Sections
- IHC Protocol 3: PAP/APAAP Immunostaining of Frozen Tissue Sections
- IHC Protocol 4: Indirect Immunostaining of Paraffin-Embedded Tissue Sections
- IHC Protocol 5: Streptavidin-Biotin Immunostaining of Paraffin-Embedded Tissue Sections
- IHC Protocol 6: PAP/APAAP Immunostaining of Paraffin Embedded Tissue Sections
- IHC Protocol 7: Antigen Retrieval Techniques for use with Formalin-Fixed Paraffin-Embedded Sections
- IHC Protocol 8: Guidance for Staining with Mouse anti-Bromodeoxyuridine
- IHC Protocol 9: Antigen Retrieval Techniques: For use with F4/80 Immunostaining of Paraffin-Embedded Sections
- IHC Protocol 10: Fixative Recipes
-
Immunoprecipitation
- Western Blotting
-
ELISA Protocols
- Contact and Support
- Distributors
- Events and Conferences
- Help Using Website
- Careers
-
Resources
- Application Resources
- Articles
- Posters & Pathways
-
Webinars, Podcasts & Videos
- Webinar: Overcome Assay Challenges using Custom Recombinant Antibodies
- Webinar: Recombinant Antibodies as Positive Controls and Calibrators
- Webinar: Measuring Adaptive and Innate Immune Responses in Ruminants
- Webinar: Mastering IHC Staining Experiments
- Webinar: Generation of High-affinity Recombinant Antibodies for Application in Immuno-MRM
- Webinar: Optimize your Assays using Recombinant Antibodies Selected for Desired Affinity
- Webinar: Porcine CD4+ T lymphocytes and their Antigen-Specific Immune Response
- Webinar: Optimize your Flow Cytometry
- Webinar: A Question of Life or Death” - Differentiating Between Healthy and Apoptotic Cells
- Webinar: CSF1, CSF1R and Control of Macrophage Differentiation
- Webinar: “Complex or not?” Immunoprecipitation (IP) application
- Webinar: Take control of your flow cytometry
- Webinar: The making of recombinant anti-idiotypic antibodies for high performance in bioanalytical assays
- Webinar: Fluorescence and compensation in flow cytometry
- Webinar: Multicolor panel building in flow cytometry
- Webinar: Apoptosis in flow cytometry
- Product Information Sheets
- Product Brochures
- Antibody of the Week
- Buy 2 and Get a 3rd Free on All Primary Antibodies
- Blog
Formerly known as AbD Serotec, a global supplier and manufacturer of antibodies, kits, and reagents.
Copyright © 2019 Bio-Rad Laboratories, Inc. All rights reserved
Copyright © 2019 Bio-Rad Laboratories, Inc. All rights reserved
Ordering
Payment methods we support:
- Invoice / Purchase Order
- Credit card
Follow us on
|
|
|
|
|
Also accessible on: |
||||
|
||||